Serena Bodei

568 total citations
18 papers, 479 citations indexed

About

Serena Bodei is a scholar working on Molecular Biology, Urology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Serena Bodei has authored 18 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Urology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Serena Bodei's work include Urinary Bladder and Prostate Research (8 papers), Hormonal and reproductive studies (4 papers) and Bone health and treatments (3 papers). Serena Bodei is often cited by papers focused on Urinary Bladder and Prostate Research (8 papers), Hormonal and reproductive studies (4 papers) and Bone health and treatments (3 papers). Serena Bodei collaborates with scholars based in Italy, United States and Netherlands. Serena Bodei's co-authors include Sandra Sigala, PierFranco Spano, Danilo Zani, Claudio Simeone, Cristina Missale, M. G. Spillantini, Arianna Bellucci, Laura Navarria, Michela Zaltieri and Leontino Battistin and has published in prestigious journals such as Journal of Neurochemistry, Experimental Cell Research and Pharmacological Research.

In The Last Decade

Serena Bodei

17 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serena Bodei Italy 11 181 123 109 107 72 18 479
Katerina K. Papachroni Greece 9 265 1.5× 90 0.7× 95 0.9× 180 1.7× 18 0.3× 10 661
Lina Vardouli Greece 8 246 1.4× 75 0.6× 72 0.7× 40 0.4× 13 0.2× 11 486
Sabina Barresi Italy 19 490 2.7× 128 1.0× 200 1.8× 66 0.6× 30 0.4× 68 842
Stephen Sikkink United Kingdom 15 407 2.2× 83 0.7× 56 0.5× 204 1.9× 133 1.8× 20 892
Ryosuke Takahashi Japan 13 242 1.3× 54 0.4× 115 1.1× 334 3.1× 101 1.4× 41 831
Roozbeh Golshani United States 10 294 1.6× 189 1.5× 108 1.0× 21 0.2× 25 0.3× 11 593
Kelly Hares United Kingdom 15 319 1.8× 48 0.4× 195 1.8× 78 0.7× 37 0.5× 24 739
Thomas Mindos United Kingdom 7 168 0.9× 63 0.5× 344 3.2× 91 0.9× 49 0.7× 9 536
Simon Holden United Kingdom 12 296 1.6× 50 0.4× 87 0.8× 61 0.6× 14 0.2× 35 585
Alexey TITIEVSKY Finland 7 351 1.9× 60 0.5× 298 2.7× 41 0.4× 25 0.3× 8 629

Countries citing papers authored by Serena Bodei

Since Specialization
Citations

This map shows the geographic impact of Serena Bodei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Bodei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Bodei more than expected).

Fields of papers citing papers by Serena Bodei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Bodei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Bodei. The network helps show where Serena Bodei may publish in the future.

Co-authorship network of co-authors of Serena Bodei

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Bodei. A scholar is included among the top collaborators of Serena Bodei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Bodei. Serena Bodei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fragni, Martina, Sara Anna Bonini, Paola Bettinsoli, et al.. (2016). The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(5). 529–538. 34 indexed citations
2.
Fragni, Martina, Sara Anna Bonini, Armando Stabile, et al.. (2016). Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells.. PubMed. 36(3). 913–20. 16 indexed citations
3.
Fiorentini, Chiara, Serena Bodei, Martina Fragni, et al.. (2014). GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity. Experimental Cell Research. 323(1). 100–111. 61 indexed citations
4.
Bodei, Serena, Danilo Zani, Martin C. Michel, et al.. (2013). Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. Pharmacological Research. 74. 1–6. 22 indexed citations
5.
Ferrari, Vittorio, Serena Bodei, Giuseppina Arcangeli, et al.. (2012). Involvement of Target Gene Polymorphisms in 5-Fluorouracil Toxicity: A Case Report. Pharmacology. 89(1-2). 99–102. 4 indexed citations
6.
Bodei, Serena, Danilo Zani, Claudio Simeone, et al.. (2012). Acetylcholine Induces Human Detrusor Muscle Cell Proliferation: Molecular and Pharmacological Characterization. Urologia Journal. 79(2). 102–108. 4 indexed citations
7.
Bodei, Serena, Martina Fragni, Danilo Zani, et al.. (2012). GPNMB/Osteoactivin as a Malignancy Biomarker in an Experimental Model of Human Prostate Adenocarcinoma. Urologia Journal. 79(4). 240–246. 1 indexed citations
8.
Bodei, Serena, Martin C. Michel, Danilo Zani, et al.. (2011). Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa. Pharmacological Research. 64(4). 420–425. 19 indexed citations
9.
Bellucci, Arianna, Laura Navarria, Michela Zaltieri, et al.. (2010). Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson’s disease. Journal of Neurochemistry. 116(4). 588–605. 187 indexed citations
10.
Bodei, Serena, Danilo Zani, Claudio Simeone, et al.. (2010). Nerve growth factor signaling in prostate health and disease. Growth Factors. 28(3). 191–201. 32 indexed citations
11.
Dellabella, Marco, Giulio Milanese, Sandra Sigala, et al.. (2009). The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. Inflammation Research. 58(12). 829–836. 13 indexed citations
12.
Bodei, Serena, Danilo Zani, Claudio Simeone, et al.. (2008). Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract. Neurourology and Urodynamics. 28(4). 343–348. 6 indexed citations
13.
Sigala, Sandra, Serena Bodei, Cristina Missale, et al.. (2008). Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment. Molecular and Cellular Endocrinology. 284(1-2). 11–20. 20 indexed citations
14.
Sigala, Sandra, Serena Bodei, Danilo Zani, et al.. (2008). GENE EXPRESSION PROFILE OF PROSTATE CANCER CELL LINES: EFFECT OF NERVE GROWTH FACTOR TREATMENT. European Urology Supplements. 7(3). 174–174. 2 indexed citations
15.
Bodei, Serena, et al.. (2008). Should we be cautious on the use of commercially available antibodies to dopamine receptors?. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(4). 413–415. 41 indexed citations
16.
Bodei, Serena, Angelo Peroni, Giuseppe Mirabella, et al.. (2007). Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender‐dependent modifications. Neurourology and Urodynamics. 27(5). 421–428. 16 indexed citations
17.
Bodei, Serena, Danilo Zani, Giovanni Mirabella, et al.. (2007). Alpha1 Adrenoceptors in Human Urinary Tract: Expression, Distribution and Clinical Implications. Urologia Journal. 74(2). 53–60.
18.
Bodei, Serena, Danilo Zani, Angelo Peroni, et al.. (2007). Alpha1 adrenoceptors in human urinary tract:expression, distribution and clinical implications. Urologia Journal. 74(2). 53–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katerina K. Papachroni Breakdown of academic impact, for papers by Lina Vardouli Breakdown of academic impact, for papers by Sabina Barresi Breakdown of academic impact, for papers by Stephen Sikkink Breakdown of academic impact, for papers by Ryosuke Takahashi Breakdown of academic impact, for papers by Roozbeh Golshani Breakdown of academic impact, for papers by Kelly Hares Breakdown of academic impact, for papers by Thomas Mindos Breakdown of academic impact, for papers by Simon Holden Breakdown of academic impact, for papers by Alexey TITIEVSKY
Rankless by CCL
2026